Effects of Motivational Interviewing in Prison

Phase 3

Completed

• Conditions: Alcohol Abuse

• Registration Number: NCT01184612
• Lead Sponsor: Karolinska Institutet

Brief Summary

Motivational Interviewing (MI) is a communication style demonstrated to decrease drug and alcohol use. A five session MI intervention (BSF) was implemented in the Swedish correctional system. The intervention was delivered by counsellors with workshop only MI training (BSF) or by counsellors with workshop MI training followed by peer group supervision based on audio taped feedback (BSF+).

Aim was to examine whether BSF in prisons reduces drug and alcohol use more effectively than interviews conducted according to the usual planning interview routine (UPI).

Detailed Description

Not available

Study Timeline

• Status Verified: 2003-10
• Study Start: 2004-04
• Primary Completion: 2007-03
• Study Completion: 2008-07
• Study First Submitted: 2010-08-18
• Study First Submitted QC: 2010-08-18
• Last Update Submitted: 2010-08-18
• Study First Posted: 2010-08-19
• Last Update Posted: 2010-08-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 296

Inclusion Criteria

• Born between 01-01-1954 and 31-12-1984;
• Conditional release no later than 30-06-2005 (this was extended to 19-09-2005 and again to 31-03-2006);
• Swedish or Norwegian speaker;
• Not having previously received BSF in remand or any other prison;
• Heavy use of alcohol or drugs, measured by the standard prison and probation system: 1= occasional use; 2= heavy use;
• ASI interview at intake;
• No order for deportation after release from prison

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
number of days with substance use	of the last 30 days	alcohol- or drug use as measured by the Addiction Severity Index (ASI) at intake and at 10 months after release

Secondary Outcome Measures

Name	Time	Method
reported days of illegal activity	during the preceding 30 days	as measured by Addiction Severity Index at intake and 10 months after release
number of days working	during the last 30 days	as measured by the Addiction Severity Index at intake and 10 months after release

Trial Locations

Locations (1)

Karolinska Institutet, Dep Clin Neuroscience; 🇸🇪 Stockholm, Sweden